Blackhawk Capital Partners LLC Purchases Shares of 7,785 Stryker Corporation $SYK

Blackhawk Capital Partners LLC acquired a new position in shares of Stryker Corporation (NYSE:SYK) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 7,785 shares of the medical technology company’s stock, valued at approximately $2,558,000. Stryker accounts for about 0.9% of Blackhawk Capital Partners LLC’s holdings, making the stock its 24th biggest position.

Several other hedge funds also recently modified their holdings of SYK. Sankala Group LLC acquired a new position in shares of Stryker during the fourth quarter valued at about $26,000. Godfrey Financial Associates Inc. acquired a new stake in shares of Stryker in the 4th quarter valued at about $26,000. United Financial Planning Group LLC bought a new stake in Stryker in the 3rd quarter valued at about $27,000. Atlas Capital Advisors Inc. acquired a new position in Stryker during the 4th quarter worth approximately $27,000. Finally, DJE Kapital AG acquired a new position in Stryker during the 4th quarter worth approximately $28,000. Institutional investors own 77.09% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on SYK shares. Deutsche Bank Aktiengesellschaft set a $315.00 price objective on Stryker in a report on Friday, May 1st. BMO Capital Markets assumed coverage on shares of Stryker in a report on Wednesday, July 8th. They set an “outperform” rating and a $369.00 price objective for the company. Leerink Partners dropped their price target on shares of Stryker from $410.00 to $407.00 and set an “outperform” rating on the stock in a research report on Friday, June 5th. Argus set a $370.00 price target on Stryker in a research note on Thursday, July 9th. Finally, Citigroup dropped their target price on Stryker from $420.00 to $385.00 and set a “buy” rating on the stock in a report on Tuesday, April 7th. One research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $392.52.

Insider Buying and Selling

In other Stryker news, Director Ronda E. Stryker sold 310,000 shares of the firm’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $312.23, for a total value of $96,791,300.00. Following the completion of the sale, the director directly owned 1,924,880 shares of the company’s stock, valued at $601,005,282.40. This trade represents a 13.87% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, VP M Kathryn Fink sold 3,500 shares of Stryker stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $283.45, for a total value of $992,075.00. Following the completion of the sale, the vice president directly owned 177 shares of the company’s stock, valued at approximately $50,170.65. This trade represents a 95.19% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 323,264 shares of company stock valued at $100,659,489. 4.60% of the stock is owned by company insiders.

Stryker Trading Up 1.7%

NYSE SYK opened at $316.46 on Thursday. The business’s fifty day moving average is $311.28 and its 200-day moving average is $337.10. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.11 and a quick ratio of 1.25. The stock has a market capitalization of $121.32 billion, a price-to-earnings ratio of 36.63, a PEG ratio of 1.99 and a beta of 0.77. Stryker Corporation has a one year low of $281.00 and a one year high of $404.87.

Stryker (NYSE:SYK) last posted its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing the consensus estimate of $2.98 by ($0.38). The company had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $6.34 billion. Stryker had a net margin of 13.20% and a return on equity of 23.42%. Stryker’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.84 EPS. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Equities research analysts predict that Stryker Corporation will post 14.98 EPS for the current year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.88 per share. The ex-dividend date is Tuesday, June 30th. This represents a $3.52 annualized dividend and a dividend yield of 1.1%. Stryker’s dividend payout ratio (DPR) is presently 40.74%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.